Skip to main content

Advertisement

SpringerLink
Log in

Triumph and tumult of matrix metalloproteinases and their crosstalk with eicosanoids in cancer

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

Cancer development and metastasis are associated to perturbation in metabolic functions of tumor cells and surrounding inflammatory and stromal cell responses. Eicosanoids and lipid mediators, in this regard, attract potential attention during cancer development. Eicosanoids, which include prostaglandin, prostacyclin, thromboxane, and leukotriene, are synthesized from arachidonic acid when cells are stimulated by stress, cytokines, or other growth factors. However, the underlying mechanism of eicosanoids in cancer development, specially their interactions with proto-oncogene factors in tumor microenvironment, remain unexplored. On the other hand, matrix metalloproteinases (MMPs) are a group of zinc-dependent endopeptidases which are involved in degradation of different extracellular matrix (ECM) proteins. MMPs are associated with different physiological responses, including embryogenesis, vasculogenesis, and cellular remodeling, as well as different disease pathogenesis. Induced MMP responses are especially associated with cancer metastasis and secondary tumor development through proteolytic cleavage of several ECM and non-ECM proteins. Although both eicosanoids and MMPs are involved with cancer progression and metastasis, the interrelation between these two molecules are less explored. The present review discusses relevant studies that connect eicosanoids and MMPs and highlight the crosstalk between them offering novel therapeutic approach in cancer treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Wang, D., & Dubois, R. N. (2010). Eicosanoids and cancer. Nature Reviews. Cancer, 10(3), 181–193. https://doi.org/10.1038/nrc2809.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Wallace, J. M. (2002). Nutritional and botanical modulation of the inflammatory cascade--eicosanoids, cyclooxygenases, and lipoxygenases--as an adjunct in cancer therapy. Integrative Cancer Therapies, 1(1), 7–37; discussion 37. https://doi.org/10.1177/153473540200100102.

    Article  PubMed  CAS  Google Scholar 

  3. Kessenbrock, K., Plaks, V., & Werb, Z. (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell, 141(1), 52–67. https://doi.org/10.1016/j.cell.2010.03.015.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Swarnakar, S., Paul, S., Singh, L. P., & Reiter, R. J. (2011). Matrix metalloproteinases in health and disease: regulation by melatonin. Journal of Pineal Research, 50(1), 8–20. https://doi.org/10.1111/j.1600-079X.2010.00812.x.

    Article  PubMed  CAS  Google Scholar 

  5. Smyth, E. M., Grosser, T., Wang, M., Yu, Y., & FitzGerald, G. A. (2009). Prostanoids in health and disease. Journal of Lipid Research, 50(Suppl), S423–S428. https://doi.org/10.1194/jlr.R800094-JLR200.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Wang, D., & Dubois, R. N. (2010). The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene, 29(6), 781–788. https://doi.org/10.1038/onc.2009.421.

    Article  PubMed  CAS  Google Scholar 

  7. Schneider, C., & Pozzi, A. (2011). Cyclooxygenases and lipoxygenases in cancer. Cancer Metastasis Reviews, 30(3–4), 277–294. https://doi.org/10.1007/s10555-011-9310-3.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Funk, C. D. (2001). rostaglandins and leukotrienes: advances in eicosanoid biology. Science, 294(5548), 1871–1875. https://doi.org/10.1126/science.294.5548.1871.

    Article  PubMed  CAS  Google Scholar 

  9. Serhan, C. N. (2011). The resolution of inflammation: the devil in the flask and in the details. The FASEB Journal, 25(5), 1441–1448. https://doi.org/10.1096/fj.11-0502ufm.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Krishnamoorthy, S., & Honn, K. V. (2008). Eicosanoids in tumor progression and metastasis. Sub-Cellular Biochemistry, 49, 145–168. https://doi.org/10.1007/978-1-4020-8831-5_6.

    Article  PubMed  Google Scholar 

  11. Nozawa, H., Chiu, C., & Hanahan, D. (2006). Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America, 103(33), 12493–12498. https://doi.org/10.1073/pnas.0601807103.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Wang, D., Wang, H., Shi, Q., Katkuri, S., Walhi, W., Desvergne, B., et al. (2004). Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta. Cancer Cell, 6(3), 285–295. https://doi.org/10.1016/j.ccr.2004.08.011.

    Article  PubMed  CAS  Google Scholar 

  13. Chizzolini, C., Chicheportiche, R., Alvarez, M., de Rham, C., Roux-Lombard, P., Ferrari-Lacraz, S., et al. (2008). Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion. Blood, 112(9), 3696–3703. https://doi.org/10.1182/blood-2008-05-155408.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Boniface, K., Bak-Jensen, K. S., Li, Y., Blumenschein, W. M., McGeachy, M. J., McClanahan, T. K., et al. (2009). Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. The Journal of Experimental Medicine, 206(3), 535–548. https://doi.org/10.1084/jem.20082293.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Scandella, E., Men, Y., Gillessen, S., Forster, R., & Groettrup, M. (2002). Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood, 100(4), 1354–1361. https://doi.org/10.1182/blood-2001-11-0017.

    Article  PubMed  CAS  Google Scholar 

  16. Wang, D., Buchanan, F. G., Wang, H., Dey, S. K., & DuBois, R. N. (2005). Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade. Cancer Research, 65(5), 1822–1829. https://doi.org/10.1158/0008-5472.Can-04-3671.

    Article  PubMed  CAS  Google Scholar 

  17. Krysan, K., Reckamp, K. L., Dalwadi, H., Sharma, S., Rozengurt, E., Dohadwala, M., et al. (2005). Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Research, 65(14), 6275–6281. https://doi.org/10.1158/0008-5472.Can-05-0216.

    Article  PubMed  CAS  Google Scholar 

  18. Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M., & Gutkind, J. S. (2005). Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science, 310(5753), 1504–1510. https://doi.org/10.1126/science.1116221.

    Article  PubMed  CAS  Google Scholar 

  19. Liou, J. Y., Ellent, D. P., Lee, S., Goldsby, J., Ko, B. S., Matijevic, N., et al. (2007). Cyclooxygenase-2-derived prostaglandin e2 protects mouse embryonic stem cells from apoptosis. Stem Cells, 25(5), 1096–1103. https://doi.org/10.1634/stemcells.2006-0505.

    Article  PubMed  CAS  Google Scholar 

  20. Ihara, A., Wada, K., Yoneda, M., Fujisawa, N., Takahashi, H., & Nakajima, A. (2007). Blockade of leukotriene B4 signaling pathway induces apoptosis and suppresses cell proliferation in colon cancer. Journal of Pharmacological Sciences, 103(1), 24–32.

    Article  PubMed  CAS  Google Scholar 

  21. Tong, W. G., Ding, X. Z., Talamonti, M. S., Bell, R. H., & Adrian, T. E. (2005). LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways. Biochemical and Biophysical Research Communications, 335(3), 949–956. https://doi.org/10.1016/j.bbrc.2005.07.166.

    Article  PubMed  CAS  Google Scholar 

  22. Buchanan, F. G., Gorden, D. L., Matta, P., Shi, Q., Matrisian, L. M., & DuBois, R. N. (2006). Role of beta-arrestin 1 in the metastatic progression of colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America, 103(5), 1492–1497. https://doi.org/10.1073/pnas.0510562103.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Ito, H., Duxbury, M., Benoit, E., Clancy, T. E., Zinner, M. J., Ashley, S. W., et al. (2004). Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2. Cancer Research, 64(20), 7439–7446. https://doi.org/10.1158/0008-5472.Can-04-1177.

    Article  PubMed  CAS  Google Scholar 

  24. Qualtrough, D., Kaidi, A., Chell, S., Jabbour, H. N., Williams, A. C., & Paraskeva, C. (2007). Prostaglandin F(2alpha) stimulates motility and invasion in colorectal tumor cells. International Journal of Cancer, 121(4), 734–740. https://doi.org/10.1002/ijc.22755.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Del Prete, A., Shao, W. H., Mitola, S., Santoro, G., Sozzani, S., & Haribabu, B. (2007). Regulation of dendritic cell migration and adaptive immune response by leukotriene B4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function. Blood, 109(2), 626–631. https://doi.org/10.1182/blood-2006-02-003665.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Woo, C. H., You, H. J., Cho, S. H., Eom, Y. W., Chun, J. S., Yoo, Y. J., et al. (2002). Leukotriene B(4) stimulates Rac-ERK cascade to generate reactive oxygen species that mediates chemotaxis. The Journal of Biological Chemistry, 277(10), 8572–8578. https://doi.org/10.1074/jbc.M104766200.

    Article  PubMed  CAS  Google Scholar 

  27. Kamiyama, M., Pozzi, A., Yang, L., DeBusk, L. M., Breyer, R. M., & Lin, P. C. (2006). EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival. Oncogene, 25(53), 7019–7028. https://doi.org/10.1038/sj.onc.1209694.

    Article  PubMed  CAS  Google Scholar 

  28. Chang, S. H., Liu, C. H., Conway, R., Han, D. K., Nithipatikom, K., Trifan, O. C., et al. (2004). Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Proceedings of the National Academy of Sciences of the United States of America, 101(2), 591–596. https://doi.org/10.1073/pnas.2535911100.

    Article  PubMed  CAS  Google Scholar 

  29. Jana, S., Chatterjee, K., Ray, A. K., DasMahapatra, P., & Swarnakar, S. (2016). Regulation of matrix metalloproteinase-2 activity by COX-2-PGE2-pAKT axis promotes angiogenesis in endometriosis. PLoS One, 11(10), e0163540. https://doi.org/10.1371/journal.pone.0163540.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Jain, S., Chakraborty, G., Raja, R., Kale, S., & Kundu, G. C. (2008). Prostaglandin E2 regulates tumor angiogenesis in prostate cancer. Cancer Research, 68(19), 7750–7759. https://doi.org/10.1158/0008-5472.Can-07-6689.

    Article  PubMed  CAS  Google Scholar 

  31. Spinella, F., Rosano, L., Di Castro, V., Natali, P. G., & Bagnato, A. (2004). Endothelin-1-induced prostaglandin E2-EP2, EP4 signaling regulates vascular endothelial growth factor production and ovarian carcinoma cell invasion. The Journal of Biological Chemistry, 279(45), 46700–46705. https://doi.org/10.1074/jbc.M408584200.

    Article  PubMed  CAS  Google Scholar 

  32. Wang, D., Wang, H., Brown, J., Daikoku, T., Ning, W., Shi, Q., et al. (2006). CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. The Journal of Experimental Medicine, 203(4), 941–951. https://doi.org/10.1084/jem.20052124.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Dormond, O., Bezzi, M., Mariotti, A., & Ruegg, C. (2002). Prostaglandin E2 promotes integrin alpha Vbeta 3-dependent endothelial cell adhesion, rac-activation, and spreading through cAMP/PKA-dependent signaling. The Journal of Biological Chemistry, 277(48), 45838–45846. https://doi.org/10.1074/jbc.M209213200.

    Article  PubMed  CAS  Google Scholar 

  34. Salcedo, R., Zhang, X., Young, H. A., Michael, N., Wasserman, K., Ma, W. H., et al. (2003). Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells. Blood, 102(6), 1966–1977. https://doi.org/10.1182/blood-2002-11-3400.

    Article  PubMed  CAS  Google Scholar 

  35. Sales, K. J., List, T., Boddy, S. C., Williams, A. R., Anderson, R. A., Naor, Z., et al. (2005). A novel angiogenic role for prostaglandin F2alpha-FP receptor interaction in human endometrial adenocarcinomas. Cancer Research, 65(17), 7707–7716. https://doi.org/10.1158/0008-5472.Can-05-0101.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Daniel, T. O., Liu, H., Morrow, J. D., Crews, B. C., & Marnett, L. J. (1999). Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Research, 59(18), 4574–4577.

    PubMed  CAS  Google Scholar 

  37. Zeddou, M., Greimers, R., de Valensart, N., Nayjib, B., Tasken, K., Boniver, J., et al. (2005). Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway. Biochemical Pharmacology, 70(5), 714–724. https://doi.org/10.1016/j.bcp.2005.05.015.

    Article  PubMed  CAS  Google Scholar 

  38. Baratelli, F., Lin, Y., Zhu, L., Yang, S. C., Heuze-Vourc'h, N., Zeng, G., et al. (2005). Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. Journal of Immunology, 175(3), 1483–1490.

    Article  CAS  Google Scholar 

  39. Verma, S., Kesh, K., Ganguly, N., Jana, S., & Swarnakar, S. (2014). Matrix metalloproteinases and gastrointestinal cancers: impacts of dietary antioxidants. World Journal of Biological Chemistry, 5(3), 355–376. https://doi.org/10.4331/wjbc.v5.i3.355.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Swarnakar, S., & Jana, S. (2018). Matrix metalloproteinase. In S. Choi (Ed.), Encyclopedia of Signaling Molecules (2nd ed., pp. 3162–3162). Cham: Springer International Publishing.

    Google Scholar 

  41. Nagase, H., Visse, R., & Murphy, G. (2006). Structure and function of matrix metalloproteinases and TIMPs. Cardiovascular Research, 69(3), 562–573. https://doi.org/10.1016/j.cardiores.2005.12.002.

    Article  PubMed  CAS  Google Scholar 

  42. Egeblad, M., & Werb, Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nature Reviews. Cancer, 2(3), 161–174. https://doi.org/10.1038/nrc745.

    Article  PubMed  CAS  Google Scholar 

  43. Ha, H. Y., Moon, H. B., Nam, M. S., Lee, J. W., Ryoo, Z. Y., Lee, T. H., et al. (2001). Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice. Cancer Research, 61(3), 984–990.

    PubMed  CAS  Google Scholar 

  44. Sternlicht, M. D., Lochter, A., Sympson, C. J., Huey, B., Rougier, J. P., Gray, J. W., et al. (1999). The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell, 98(2), 137–146.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  45. Sternlicht, M. D., & Werb, Z. (2001). How matrix metalloproteinases regulate cell behavior. Annual Review of Cell and Developmental Biology, 17, 463–516. https://doi.org/10.1146/annurev.cellbio.17.1.463.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  46. Deryugina, E. I., & Quigley, J. P. (2006). Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Reviews, 25(1), 9–34. https://doi.org/10.1007/s10555-006-7886-9.

    Article  PubMed  CAS  Google Scholar 

  47. Ichikawa, Y., Ishikawa, T., Momiyama, N., Kamiyama, M., Sakurada, H., Matsuyama, R., et al. (2006). Matrilysin (MMP-7) degrades VE-cadherin and accelerates accumulation of beta-catenin in the nucleus of human umbilical vein endothelial cells. Oncology Reports, 15(2), 311–315.

    PubMed  CAS  Google Scholar 

  48. Zheng, G., Lyons, J. G., Tan, T. K., Wang, Y., Hsu, T.-T., Min, D., et al. (2009). Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-β1 in renal tubular epithelial cells. The American Journal of Pathology, 175(2), 580–591. https://doi.org/10.2353/ajpath.2009.080983.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Chatterjee, K., Jana, S., DasMahapatra, P., & Swarnakar, S. (2018). EGFR-mediated matrix metalloproteinase-7 up-regulation promotes epithelial-mesenchymal transition via ERK1-AP1 axis during ovarian endometriosis progression. The FASEB Journal, fj201701382RR. https://doi.org/10.1096/fj.201701382RR.

  50. Suzuki, M., Raab, G., Moses, M. A., Fernandez, C. A., & Klagsbrun, M. (1997). Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. The Journal of Biological Chemistry, 272(50), 31730–31737.

    Article  PubMed  CAS  Google Scholar 

  51. Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., et al. (1998). An essential role for ectodomain shedding in mammalian development. Science, 282(5392), 1281–1284.

    Article  PubMed  CAS  Google Scholar 

  52. Vargo-Gogola, T., Crawford, H. C., Fingleton, B., & Matrisian, L. M. (2002). Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Archives of Biochemistry and Biophysics, 408(2), 155–161.

    Article  PubMed  CAS  Google Scholar 

  53. Jana, S., Paul, S., & Swarnakar, S. (2012). Curcumin as anti-endometriotic agent: implication of MMP-3 and intrinsic apoptotic pathway. Biochemical Pharmacology, 83(6), 797–804. https://doi.org/10.1016/j.bcp.2011.12.030.

    Article  PubMed  CAS  Google Scholar 

  54. Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., et al. (2000). Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biology, 2(10), 737–744.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  55. Lee, S., Jilani, S. M., Nikolova, G. V., Carpizo, D., & Iruela-Arispe, M. L. (2005). Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. The Journal of Cell Biology, 169(4), 681–691. https://doi.org/10.1083/jcb.200409115.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  56. Sheu, B. C., Hsu, S. M., Ho, H. N., Lien, H. C., Huang, S. C., & Lin, R. H. (2001). A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Research, 61(1), 237–242.

    PubMed  CAS  Google Scholar 

  57. Yu, Q., & Stamenkovic, I. (2000). Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes & Development, 14(2), 163–176.

    Google Scholar 

  58. Gorelik, L., & Flavell, R. A. (2001). Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells. Nature Medicine, 7(10), 1118–1122.

    Article  PubMed  CAS  Google Scholar 

  59. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., et al. (1994). Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79(2), 315–328.

    Article  PubMed  CAS  Google Scholar 

  60. Patterson, B. C., & Sang, Q. A. (1997). Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). Journal of Biological Chemistry, 272(46), 28823–28825. https://doi.org/10.1074/jbc.272.46.28823.

    Article  PubMed  CAS  Google Scholar 

  61. Heljasvaara, R., Nyberg, P., Luostarinen, J., Parikka, M., Heikkila, P., Rehn, M., et al. (2005). Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases. Experimental Cell Research, 307(2), 292–304. https://doi.org/10.1016/j.yexcr.2005.03.021.

    Article  PubMed  CAS  Google Scholar 

  62. Hamano, Y. (2003). Physiological levels of tumstatin, a fragment of collagen IV [alpha]3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via [alpha]V [beta]3 integrin. Cancer Cell, 3, 589–601.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  63. Derynck, R., Akhurst, R. J., & Balmain, A. (2001). TGF-beta signaling in tumor suppression and cancer progression. Nature Genetics, 29(2), 117–129. https://doi.org/10.1038/ng1001-117.

    Article  PubMed  CAS  Google Scholar 

  64. Wang, X., & Lin, Y. (2008). Tumor necrosis factor and cancer, buddies or foes? Acta Pharmacologica Sinica, 29(11), 1275–1288. https://doi.org/10.1111/j.1745-7254.2008.00889.x.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  65. Overall, C. M., & Lopez-Otin, C. (2002). Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nature Reviews. Cancer, 2(9), 657–672. https://doi.org/10.1038/nrc884.

    Article  PubMed  CAS  Google Scholar 

  66. Bramhall, S. R., Rosemurgy, A., Brown, P. D., Bowry, C., & Buckels, J. A. (2001). Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial. Journal of Clinical Oncology, 19(15), 3447–3455. https://doi.org/10.1200/jco.2001.19.15.3447.

    Article  PubMed  CAS  Google Scholar 

  67. Cathcart, J., Pulkoski-Gross, A., & Cao, J. (2015). Targeting matrix metalloproteinases in cancer: bringing new life to old ideas. Genes & Diseases, 2(1), 26–34. https://doi.org/10.1016/j.gendis.2014.12.002.

    Article  CAS  Google Scholar 

  68. Hu, J., Van den Steen, P. E., Sang, Q. X., & Opdenakker, G. (2007). Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nature Reviews. Drug Discovery, 6(6), 480–498. https://doi.org/10.1038/nrd2308.

    Article  PubMed  CAS  Google Scholar 

  69. Greene, E. R., Huang, S., Serhan, C. N., & Panigrahy, D. (2011). Regulation of inflammation in cancer by eicosanoids. Prostaglandins & Other Lipid Mediators, 96(1–4), 27–36. https://doi.org/10.1016/j.prostaglandins.2011.08.004.

    Article  CAS  Google Scholar 

  70. Ishikawa, T. O., & Herschman, H. R. (2010). Tumor formation in a mouse model of colitis-associated colon cancer does not require COX-1 or COX-2 expression. Carcinogenesis, 31(4), 729–736. https://doi.org/10.1093/carcin/bgq002.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  71. Pavlovic, S., Du, B., Sakamoto, K., Khan, K. M., Natarajan, C., Breyer, R. M., et al. (2006). Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages. The Journal of Biological Chemistry, 281(6), 3321–3328. https://doi.org/10.1074/jbc.M506846200.

    Article  PubMed  CAS  Google Scholar 

  72. Itatsu, K., Sasaki, M., Yamaguchi, J., Ohira, S., Ishikawa, A., Ikeda, H., et al. (2009). Cyclooxygenase-2 is involved in the up-regulation of matrix metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis factor-alpha. The American Journal of Pathology, 174(3), 829–841. https://doi.org/10.2353/ajpath.2009.080012.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  73. Yen, J. H., Kocieda, V. P., Jing, H., & Ganea, D. (2011). Prostaglandin E2 induces matrix metalloproteinase 9 expression in dendritic cells through two independent signaling pathways leading to activator protein 1 (AP-1) activation. The Journal of Biological Chemistry, 286(45), 38913–38923. https://doi.org/10.1074/jbc.M111.252932.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  74. Hsu, H. H., Hu, W. S., Lin, Y. M., Kuo, W. W., Chen, L. M., Chen, W. K., et al. (2011). JNK suppression is essential for 17beta-estradiol inhibits prostaglandin E2-induced uPA and MMP-9 expressions and cell migration in human LoVo colon cancer cells. Journal of Biomedical Science, 18, 61. https://doi.org/10.1186/1423-0127-18-61.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  75. Zahner, G., Harendza, S., Muller, E., Wolf, G., Thaiss, F., & Stahl, R. A. (1997). Prostaglandin E2 stimulates expression of matrix metalloproteinase 2 in cultured rat mesangial cells. Kidney International, 51(4), 1116–1123.

    Article  PubMed  CAS  Google Scholar 

  76. Choi, Y. A., Lee, D. J., Lim, H. K., Jeong, J. H., Sonn, J. K., Kang, S. S., et al. (2004). Interleukin-1beta stimulates matrix metalloproteinase-2 expression via a prostaglandin E2-dependent mechanism in human chondrocytes. Experimental & Molecular Medicine, 36(3), 226–232. https://doi.org/10.1038/emm.2004.31.

    Article  CAS  Google Scholar 

  77. Sato, T., Konomi, K., Fujii, R., Aono, H., Aratani, S., Yagishita, N., et al. (2011). Prostaglandin EP2 receptor signalling inhibits the expression of matrix metalloproteinase 13 in human osteoarthritic chondrocytes. Annals of the Rheumatic Diseases, 70(1), 221–226. https://doi.org/10.1136/ard.2009.118620.

    Article  PubMed  CAS  Google Scholar 

  78. Fernandez-Patron, C., & Leung, D. (2015). Emergence of a metalloproteinase/phospholipase A2 axis of systemic inflammation. Metalloproteinases in Medicine, 2, 29–38. https://doi.org/10.2147/mnm.S48748.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Hernandez-Anzaldo, S., Berry, E., Brglez, V., Leung, D., Yun, T. J., Lee, J. S., et al. (2015). Identification of a novel heart-liver axis: matrix metalloproteinase-2 negatively regulates cardiac secreted phospholipase A2 to modulate lipid metabolism and inflammation in the liver. Journal of the American Heart Association, 4(11). https://doi.org/10.1161/jaha.115.002553.

  80. Weinreb, R. N., Kashiwagi, K., Kashiwagi, F., Tsukahara, S., & Lindsey, J. D. (1997). Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Investigative Ophthalmology & Visual Science, 38(13), 2772–2780.

    CAS  Google Scholar 

  81. Li, X., & Tai, H. H. (2012). Increased expression of matrix metalloproteinases mediates thromboxane A2-induced invasion in lung cancer cells. Current Cancer Drug Targets, 12(6), 703–715.

    Article  PubMed  CAS  Google Scholar 

  82. Hartney, J. M., Gustafson, C. E., Bowler, R. P., Pelanda, R., & Torres, R. M. (2011). Thromboxane receptor signaling is required for fibronectin-induced matrix metalloproteinase 9 production by human and murine macrophages and is attenuated by the Arhgef1 molecule. The Journal of Biological Chemistry, 286(52), 44521–44531. https://doi.org/10.1074/jbc.M111.282772.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  83. Kummer, N. T., Nowicki, T. S., Azzi, J. P., Reyes, I., Iacob, C., Xie, S., et al. (2012). Arachidonate 5 lipoxygenase expression in papillary thyroid carcinoma promotes invasion via MMP-9 induction. Journal of Cellular Biochemistry, 113(6), 1998–2008. https://doi.org/10.1002/jcb.24069.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  84. Hennig, R., Kehl, T., Noor, S., Ding, X. Z., Rao, S. M., Bergmann, F., et al. (2007). 15-lipoxygenase-1 production is lost in pancreatic cancer and overexpression of the gene inhibits tumor cell growth. Neoplasia, 9(11), 917–926.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  85. Ichiyama, T., Kajimoto, M., Hasegawa, M., Hashimoto, K., Matsubara, T., & Furukawa, S. (2007). Cysteinyl leukotrienes enhance tumour necrosis factor-alpha-induced matrix metalloproteinase-9 in human monocytes/macrophages. Clinical and Experimental Allergy, 37(4), 608–614. https://doi.org/10.1111/j.1365-2222.2007.02692.x.

    Article  PubMed  CAS  Google Scholar 

  86. Rajah, R., Nunn, S. E., Herrick, D. J., Grunstein, M. M., & Cohen, P. (1996). Leukotriene D4 induces MMP-1, which functions as an IGFBP protease in human airway smooth muscle cells. The American Journal of Physiology, 271(6 Pt 1), L1014–L1022. https://doi.org/10.1152/ajplung.1996.271.6.L1014.

    Article  PubMed  CAS  Google Scholar 

  87. Piromkraipak, P., Sangpairoj, K., Tirakotai, W., Chaithirayanon, K., Unchern, S., Supavilai, P., et al. (2018). Cysteinyl leukotriene receptor antagonists inhibit migration, invasion, and expression of MMP-2/9 in human glioblastoma. Cellular and Molecular Neurobiology, 38(2), 559–573. https://doi.org/10.1007/s10571-017-0507-z.

    Article  PubMed  CAS  Google Scholar 

  88. Chandrasekharan, J. A., & Sharma-Walia, N. (2015). Lipoxins: nature’s way to resolve inflammation. Journal of Inflammation Research, 8, 181–192. https://doi.org/10.2147/jir.S90380.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Zong, L., Li, J., Chen, X., Chen, K., Li, W., Li, X., et al. (2016). Lipoxin A4 attenuates cell invasion by inhibiting ROS/ERK/MMP pathway in pancreatic cancer. Oxidative Medicine and Cellular Longevity, 2016, 6815727. https://doi.org/10.1155/2016/6815727.

    Article  PubMed  CAS  Google Scholar 

  90. Chen, Q. H., Zhou, W. D., Pu, D. M., Huang, Q. S., Li, T., & Chen, Q. X. (2010). 15-Epi-lipoxin A(4) inhibits the progression of endometriosis in a murine model. Fertility and Sterility, 93(5), 1440–1447. https://doi.org/10.1016/j.fertnstert.2009.01.107.

    Article  PubMed  CAS  Google Scholar 

  91. Leppert, D., Hauser, S. L., Kishiyama, J. L., An, S., Zeng, L., & Goetzl, E. J. (1995). Stimulation of matrix metalloproteinase-dependent migration of T cells by eicosanoids. The FASEB Journal, 9(14), 1473–1481.

    Article  PubMed  CAS  Google Scholar 

  92. Yu, W., Chen, L., Yang, Y. Q., Falck, J. R., Guo, A. M., Li, Y., et al. (2011). Cytochrome P450 omega-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer. Cancer Chemotherapy and Pharmacology, 68(3), 619–629. https://doi.org/10.1007/s00280-010-1521-8.

    Article  PubMed  CAS  Google Scholar 

  93. Moshal, K. S., Zeldin, D. C., Sithu, S. D., Sen, U., Tyagi, N., Kumar, M., et al. (2008). Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia. Journal of Cellular Physiology, 215(3), 771–781. https://doi.org/10.1002/jcp.21356.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  94. Michaelis, U. R., Fisslthaler, B., Barbosa-Sicard, E., Falck, J. R., Fleming, I., & Busse, R. (2005). Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis. Journal of Cell Science, 118(Pt 23), 5489–5498. https://doi.org/10.1242/jcs.02674.

    Article  PubMed  CAS  Google Scholar 

  95. Calder, P. C. (2013). Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? British Journal of Clinical Pharmacology, 75(3), 645–662. https://doi.org/10.1111/j.1365-2125.2012.04374.x.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  96. Taguchi, A., Kawana, K., Tomio, K., Yamashita, A., Isobe, Y., Nagasaka, K., et al. (2014). Matrix metalloproteinase (MMP)-9 in cancer-associated fibroblasts (CAFs) is suppressed by omega-3 polyunsaturated fatty acids in vitro and in vivo. PLoS One, 9(2), e89605. https://doi.org/10.1371/journal.pone.0089605.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Biology & Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, 4-Raja S.C. Mullick Road, Jadavpur, Kolkata, 700032, India

    Kasturi Chatterjee, Sayantan Jana, Preety Choudhary & Snehasikta Swarnakar

Authors
  1. Kasturi Chatterjee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sayantan Jana
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Preety Choudhary
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Snehasikta Swarnakar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Snehasikta Swarnakar.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chatterjee, K., Jana, S., Choudhary, P. et al. Triumph and tumult of matrix metalloproteinases and their crosstalk with eicosanoids in cancer. Cancer Metastasis Rev 37, 279–288 (2018). https://doi.org/10.1007/s10555-018-9756-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10555-018-9756-7

Keywords

Search

Navigation